Segment Overview: Dr. George Savage, Chief Medical Officer, Proteus Digital Health, talks about digital medicine, Proteus Discover and the new Abilify Mycite (R) which was just granted an NDA approval by the FDA. The digital medicine has indigestible sensors, a wearable sensor patch, mobile device application and a provider portal.
Guest: Dr. George Savage
Presenter: Neal Howard
Guest Bio: George Savage is chief medical officer and co-founder of Proteus Digital Health, and formerly the company’s vice president of research and development. He sees Digital Medicine as an invaluable collaboration platform for patient and physician, integrating information about a patient’s response to therapy directly into everyday healthcare. George is focused on developing the clinical and economic evidence needed to secure global regulatory approvals and spur widespread adoption of Proteus’ ingestible sensor platform. He serves on the board of the California Life Sciences Association, the Boston University College of Engineering advisory council, and in 2016 was elected a Fellow of the American Institute for Medical and Biological Engineering.